The company and one of its subsidiaries would allegedly confuse clinicians and have them bill government programs for cardiac monitoring services that were more expensive than what they needed. This settlement resolves those allegations. 

The alleged scheme involved a series of diagnostic procedures that, according to the U.S. government, were not medically necessary. 

The policies cover a wide range of interventional therapies, including Shockwave Medical's IVL technology and intravascular ultrasound. 

Ultromics thinks the significant payment increase will help ramp up utilization among U.S. healthcare providers.

Implanting the Barostim device is now associated with an average payment amount of $45,000, up significantly from the previous average of $29,000.

More than 100 U.S. medical societies are throwing their support behind a new proposal that could reform out-of-date Medicare policies and help limit future payment cuts. 

Intravascular lithotripsy therapy to break up calcified coronary lesions will now be reimbursed at a higher rate under new in-hospital codes the went into effect Oct. 1.

Ken Rosenfield, MD, helped spearhead the recent Medicare policy change that made carotid stenting procedures available to more patients.